This discussion aims at capturing and sharing the experience and knowledge of sectors and communities, which have been using nano-enabled or nano-formulated products.
TENTH TOPIC "Methodological needs in the quality and safety characterisation of nanotechnology-based health products: Priorities for method development and standardisation" (
FIRST TOPIC: Regulatory information needed for nanotech-enabled products. QUESTION: Do you think the existing guidance is sufficient for regulating nano-enabled health products?
SECOND TOPIC: Selection of the regulatory framework. QUESTION: Can we always clearly define the primary mode of action of nano-enabled health products?
THIRD TOPIC: The European definition of nanomaterial and its implication for nanotechnology-enabled health products QUESTION: Is it clear how to interpret EC definition of nanomaterial as used in medicaldevice regulation?
FOURTH TOPIC: The assessment of follow-on nanoproducts (called nanosimilars). QUESTION: Is the existing regulatory framework for assessing the equivalence of generic products sufficient for follow-on nanomedicinal products?
FIFTH TOPIC: Methods addressing regulatory information needs. QUESTION: Can existing standards provide the information needed for regulatory decision making?
NINTH TOPIC: Assessment of the similarities of the nanotechnology products. Are the existing tools adequate to support similarity assessment, grouping and/or read across in your sector?
Incidents driven by cultural or religious intolerance are shocking and can lead to apprehensiveness in the communities in which they occur. How can we foster greater understanding in our young children?